Al-Dawaa Medical Services Company
4163.SRSAUHealthcare● Active
$43.82
+$0.26(+0.60%)
Market Cap$3.7B
P/E Ratio—
52W High$80.05
52W Low$43
Al-Dawaa Medical Services Company (4163.SR) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · 4163.SR · as of 2026-06-15
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $6.74B | $6.45B | $5.74B | $5.37B | $5.03B |
| Cost of Revenue | $4.36B | $4.16B | $3.68B | $3.35B | $3.14B |
| Gross Profit | $2.37B | $2.29B | $2.06B | $2.02B | $1.89B |
| Gross Margin %(computed) | 35.23% | 35.55% | 35.96% | 37.59% | 37.63% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.04B | $0.04B | $0.05B | $0.05B |
| Total Operating Expenses | $1.91B | $1.78B | $1.60B | $1.65B | $1.62B |
| Operating Income | $0.46B | $0.51B | $0.47B | $0.37B | $0.27B |
| Operating Margin %(computed) | 6.89% | 7.97% | 8.13% | 6.87% | 5.32% |
| Interest Income | $0.00B | ($0.02B) | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.11B | $0.12B | $0.12B | $0.12B | $0.08B |
| Income Before Tax | $0.33B | $0.39B | $0.34B | $0.32B | $0.25B |
| Income Tax Expense | $0.01B | $0.02B | $0.01B | $0.01B | $0.01B |
| Net Income | $0.32B | $0.37B | $0.33B | $0.31B | $0.24B |
| Net Margin %(computed) | 4.78% | 5.74% | 5.73% | 5.69% | 4.75% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $3.79 | $4.35 | $3.87 | $3.59 | $2.81 |
| Wtd Avg Shares | 0.08B | 0.09B | 0.09B | 0.09B | 0.09B |
| EBITDA | $0.88B | $0.90B | $0.83B | $0.78B | $0.66B |
| EBITDA Margin %(computed) | 13.08% | 13.90% | 14.46% | 14.60% | 13.16% |
Data source: Financial Modeling Prep · Last updated: 2026-06-15 · SAR · B
Explore more Al-Dawaa Medical Services Company data
About Al-Dawaa Medical Services Company (4163.SR) Income Statement
Al-Dawaa Medical Services Company (4163.SR) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, 4163.SR reported revenue of $6.74B, gross profit of $2.37B (gross margin 35.23%), and net income of $0.32B — a net profit margin of 4.78%.
Frequently asked questions
4163.SR · 4 questionsAl-Dawaa Medical Services Company (4163.SR) reported revenue of $6.74B for 2025, up 4.4% year-over-year.
4163.SR revenue4163.SR salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15